Literature DB >> 31327618

Multibranched endovascular aortic aneurysm repair in patients with and without chronic aortic dissections.

Evan C Werlin1, Smita Kaushik2, Warren J Gasper2, Megan Hoffman2, Linda M Reilly2, Timothy A Chuter2, Jade S Hiramoto3.   

Abstract

OBJECTIVE: The objective of this study was to compare multibranched endovascular aneurysm repair (MBEVAR) of postdissection thoracoabdominal aortic aneurysms (TAAAs) and pararenal aortic aneurysms (PRAAs) with MBEVAR of degenerative TAAAs and PRAAs and to assess the role played by the preoperative correction of potential complicating factors, such as true lumen compression and false lumen origin of vital branches, using adjunctive maneuvers.
METHODS: From July 2005 to July 2017, there were 162 patients who underwent elective MBEVAR of TAAAs and PRAAs. Data on demographics, procedural details, and outcomes were collected prospectively.
RESULTS: The mean age was 73 ± 8 years, and 119 of 162 (74%) were men; 19 of 162 (12%) had prior aortic dissections. Patients with dissections were younger (65 ± 11 years vs 74 ± 7 years; P = .002) and were less likely to have smoked (13/19 [68%] vs 135/143 [94%]; P = .002) or to have peripheral artery disease (0/19 [0%] vs 35/143 [24%]; P = .01) compared with those without dissections. Patients with prior dissections were more likely to have Crawford type II (10/19 [53%] vs 22/143 [15%]; P = .001) and type III (6/19 [32%] vs 16/143 [11%]; P = .03) TAAAs and were more likely to require at least one pre-MBEVAR adjunctive procedure (14/19 [74%] vs 55/143 [38%]; P = .006) compared with those without dissection. There was no difference in perioperative death, stroke, or paraplegia rates between the two groups. Median follow-up was 2.4 years (interquartile range, 0.8-4.7) and did not differ significantly between the two groups. There were no significant differences in branch vessel occlusion, endoleak rate, or aneurysm-related death between the two groups.
CONCLUSIONS: Patients with chronic type B aortic dissection are more likely to have extensive aneurysms and more likely to require adjunctive procedures to provide the appropriate anatomic substrate for MBEVAR, but this does not appear to affect the conduct of MBEVAR or its outcomes.
Copyright © 2019 Society for Vascular Surgery. All rights reserved.

Entities:  

Keywords:  Aortic aneurysm; Branched stent graft; Dissection

Mesh:

Year:  2019        PMID: 31327618      PMCID: PMC6815245          DOI: 10.1016/j.jvs.2019.02.048

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  15 in total

Review 1.  Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association.

Authors:  Michael A Coady; John S Ikonomidis; Albert T Cheung; Alan H Matsumoto; Michael D Dake; Elliot L Chaikof; Richard P Cambria; Christina T Mora-Mangano; Thoralf M Sundt; Frank W Sellke
Journal:  Circulation       Date:  2010-06-07       Impact factor: 29.690

2.  Staged hybrid repair of extensive thoracoabdominal aortic aneurysms secondary to chronic aortic dissection.

Authors:  Amit Jain; Tanya F Flohr; William F Johnston; Margaret C Tracci; Kenneth J Cherry; Gilbert R Upchurch; John A Kern; Ravi K Ghanta
Journal:  J Vasc Surg       Date:  2015-10-01       Impact factor: 4.268

Review 3.  Techniques and outcomes of secondary endovascular repair for postdissection TAA/TAAA.

Authors:  Pablo Marques de Marino; Kyriakos Oikonomou; Eric L Verhoeven; Athanasios Katsargyris
Journal:  J Cardiovasc Surg (Torino)       Date:  2018-05-23       Impact factor: 1.888

Review 4.  Open surgery for chronic dissection.

Authors:  Jason Constantinou; Arun Kelay; Tara M Mastracci
Journal:  J Vasc Surg       Date:  2016-05       Impact factor: 4.268

5.  Open surgical repair of post-dissection thoraco-abdominal aortic aneurysms: early and late outcomes of a single-centre study involving over 200 patients.

Authors:  Jacopo Alfonsi; Giacomo Murana; Henri G Smeenk; Hans Kelder; Marc Schepens; Uday Sonker; Wim J Morshuis; Robin H Heijmen
Journal:  Eur J Cardiothorac Surg       Date:  2018-08-01       Impact factor: 4.191

6.  Endovascular treatment of thoracoabdominal aortic aneurysms.

Authors:  Timothy A M Chuter; Joseph H Rapp; Jade S Hiramoto; Darren B Schneider; Benjamin Howell; Linda M Reilly
Journal:  J Vasc Surg       Date:  2007-11-05       Impact factor: 4.268

7.  Long-term predictors of descending aorta aneurysmal change in patients with aortic dissection.

Authors:  Jong-Min Song; Sung-Doo Kim; Jeong-Hoon Kim; Mi-Jeong Kim; Duk-Hyun Kang; Joon Beom Seo; Tae-Hwan Lim; Jae Won Lee; Meong-Gun Song; Jae-Kwan Song
Journal:  J Am Coll Cardiol       Date:  2007-08-06       Impact factor: 24.094

8.  Complex endovascular repair of postdissection arch and thoracoabdominal aneurysms.

Authors:  Rafaëlle Spear; Adrien Hertault; Katrien Van Calster; Nicla Settembre; Matthieu Delloye; Richard Azzaoui; Jonathan Sobocinski; Dominique Fabre; Mark Tyrrell; Stéphan Haulon
Journal:  J Vasc Surg       Date:  2017-11-15       Impact factor: 4.268

9.  Efficacy of thoracic endovascular stent repair for chronic type B aortic dissection with aneurysmal degeneration.

Authors:  Salvatore T Scali; Robert J Feezor; Catherine K Chang; David H Stone; Philip J Hess; Tomas D Martin; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2013-04-03       Impact factor: 4.268

10.  True-lumen and false-lumen diameter changes in the downstream aorta after frozen elephant trunk implantation.

Authors:  Tim Berger; Maximilian Kreibich; Julia Morlock; Stoyan Kondov; Johannes Scheumann; Fabian A Kari; Bartosz Rylski; Matthias Siepe; Friedhelm Beyersdorf; Martin Czerny
Journal:  Eur J Cardiothorac Surg       Date:  2018-08-01       Impact factor: 4.191

View more
  1 in total

Review 1.  Endovascular strategies for post-dissection aortic aneurysm (PDAA).

Authors:  Zhaoxiang Zeng; Yuxi Zhao; Mingwei Wu; Xianhao Bao; Tao Li; Jiaxuan Feng; Rui Feng; Zaiping Jing
Journal:  J Cardiothorac Surg       Date:  2020-10-01       Impact factor: 1.637

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.